LA
BIIB icon

LVW Advisors’s Biogen BIIB Stock Holding History

LVW Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$249K Sell
1,154
-535
-32% -$102K 0.02% 389
2026
Q1 		$310K Buy
+1,689
New +$311K 0.03% 320

Other funds holding BIIB

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ADEF
Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

LVW Advisors's BIIB Position: Q2 2026 in Review

LVW Advisors reduced its Biogen (BIIB) stake by 32% in Q2 2026, selling an estimated $102K and leaving 1,154 shares worth $249K. The position accounts for 0.02% of the portfolio, ranked #389.

LVW Advisors first reported a position in BIIB in Q1 2026 and has held it in 2 quarters since. The position peaked at $310K in Q1 2026. 380 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • LVW Advisors held 1,154 shares of Biogen worth $249K as of Q2 2026.
  • LVW Advisors sold 535 Biogen shares in Q2 2026, an estimated $102K.
  • Biogen made up 0.02% of LVW Advisors's portfolio in Q2 2026, its #389 holding.
  • LVW Advisors first reported a position in Biogen in Q1 2026 and has held it in 2 quarters since.
  • LVW Advisors's Biogen position peaked at $310K in Q1 2026.
  • 380 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on LVW Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.